Theravance Biopharma, Inc.

TBPH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001583107

SEC filings (opens in a new tab)

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Theravance Biopharma, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of TBPH: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	161	2	169	+10
Shares	48.4M	13.3K	49.6M	+1.23M (+2.5%)
Value	$706.3M	$194.8K	$927.2M	+$221.1M (+31.3%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Theravance Biopharma, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to TBPH in Q4 2025
Institution	Shares	Value	% of portfolio
Pacer Advisors, Inc.	338,958	$6.34M	0.02%
Rock Springs Capital Management LP	208,771	$3.91M	0.20%
Nomura Asset Management International Inc.	208,783	$3.91M	0.01%
Sierra Summit Advisors LLC	59,371	$1.11M	0.17%
Canada Pension Plan Investment Board	49,700	$929.9K	0.00%
SEI Investments Co	40,720	$761.9K	0.00%
Mackenzie Financial Corp	37,329	$704.5K	0.00%
Ellsworth Advisors, LLC	33,332	$670.3K	0.13%
Aviva PLC	26,810	$501.6K	0.00%
Legato Capital Management LLC	26,157	$489.4K	0.04%
Gotham Asset Management, LLC	22,680	$424.3K	0.00%
Y-Intercept (Hong Kong) Ltd	18,686	$349.6K	0.01%
Magnetar Financial LLC	16,977	$317.6K	0.00%
Prudential Financial Inc	16,665	$311.8K	0.00%
Schonfeld Strategic Advisors LLC	16,555	$309.7K	0.00%
First Trust Advisors LP	15,860	$296.7K	0.00%
State of Wisconsin Investment Board	14,860	$278.0K	0.00%
James Investment Research Inc	14,833	$277.5K	0.03%
Entropy Technologies, LP	11,882	$222.3K	0.01%
Private Advisor Group, LLC	11,036	$206.5K	0.00%
Bank of Nova Scotia	10,649	$199.2K	0.00%
Virtus ETF Advisers LLC	9,100	$170.3K	0.08%
SHP Wealth Management	670	$12.5K	0.00%
UBS Asset Management Americas Inc	399	$7.46K	0.00%
C M Bidwell & Associates Ltd	255	$4.77K	0.00%
Covestor Ltd	33	$1.00K	0.00%
True Wealth Design, LLC	2	$38	0.00%

Sold out (17)

Institutions that held Theravance Biopharma, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of TBPH in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Macquarie Group Ltd	208,783	$3.05M
Algert Global LLC	199,705	$2.92M
NJ State Employees Deferred Compensation Plan	58,142	$848.9K
Walleye Capital LLC	29,395	$429.2K
Jain Global LLC	20,204	$295.0K
Balyasny Asset Management LLC	20,098	$293.4K
Aquatic Capital Management LLC	16,768	$244.8K
Longboard Asset Management, LP	13,102	$191.3K
Yakira Capital Management, Inc.	12,622	$184.3K
Sherbrooke Park Advisers LLC	12,189	$178.0K
Petrus Trust Company, LTA	12,047	$175.9K
PharVision Advisers, LLC	10,751	$157.0K
CIBC Private Wealth Group, LLC	4,685	$68.4K
Quarry LP	1,776	$25.9K
Clearstead Advisors, LLC	20	$292
Wealthspire Advisors, LLC	12	$175
SBI Securities Co., Ltd.	2	$29

Not filed for Q4 2025 yet (2)

Institutions that held Theravance Biopharma, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TBPH in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Cubist Systematic Strategies, LLC	13,341	$194.8K
Point72 Asia (Singapore) Pte. Ltd.	2	$24